Abstract: Research on human immune responses frequently involves the use of peripheral blood mononuclear cells (PBMC) immediately, or at significantly delayed timepoints, after collection. This requires PBMC isolation from whole blood and cryopreservation for some applications. It is important to standardize protocols for blood collection, PBMC isolation, cryopreservation, and thawing that maximize survival and functionality of PBMC at the time of analysis. This resource includes detailed protocols describing blood collection tubes, isolation of PBMC using a density gradient, cryopreservation of PBMC, and thawing of cells as well as preparation for functional assays. For each protocol, we include important considerations, such as timing, storage temperatures, and freezing rate. In addition, we provide alternatives so that researchers can make informed decisions in determining the optimal protocol for their application.
S
tudies of the human immune system often involve isolation of peripheral blood mononuclear cells (PBMCs), and appropriate protocols for isolation and storage of PBMCs are important to facilitate this research. Here, we provide standard operating protocols for the acquisition, isolation, freezing, storage, and thawing of PBMC.
Obtaining live blood cells for analysis requires the use of anticoagulants during blood collection. The choice of collection tube depends on the ultimate downstream applications. Commonly used anticoagulants include ethylenediaminetetraacetic acid (EDTA) (in purple or lavender top vacutainers), acid citrate dextrose (ACD) (yellow top vacutainers), sodium citrate (light blue top vacutainers), and sodium heparin (green top vacutainers). Because additives used in blood collection can affect the suitability of the cells for downstream assays, careful consideration should be made in deciding which type of vacutainers to use for blood collection. For example, EDTA has been shown to interfere with antigen-specific T-cell responses by some, 1 but not others 2 when compared with blood collected using ACD or heparin. Sodium heparin binds to DNA and interferes with many enzymes used for molecular analyses of DNA therefore should be avoided when the cells are destined for gene expression analyses. 3 Cyto-Chex tubes contain fixatives that preserve the blood cells for later flow cytometric analysis; however, fixatives in Cyto-Chex tubes kill cells and can also destroy certain antigens for flow cytometric detection. 4 The most commonly used method to isolate PBMCs from blood is density gradient centrifugation using Ficoll. To achieve high yield and purity of cells with reproducibility, multiple parameters need to be considered, such as blood storage condition before processing, choice of blood diluent, Ficoll underlay/overlay technique, and centrifugation conditions. Special blood collection tubes are also available to reduce the variability, such as cell preparation tubes (CPT), prepackaged with a polyester gel and density gradient medium so that they can be directly centrifuged to separate PBMCs from RBC and granulocytes and plasma. The CPT tubes are available with the various anticoagulants as described above.
There are several reasons to store samples for in vitro studies including the need to batch analyses, 5 and to preserve samples for analyses that may not be immediately possible. When storing PBMC, time, and temperature before PBMC isolation, between isolation and freezing, rate of freezing, duration of cryopreservation, and storage temperature can all affect cell viability and functionality. Before deciding to cryopreserve cells, it is important to consider what is most important to the experiment at hand. For example, some cellular functions 6, 7 and phenotypes 8 can be affected by cryopreservation, so for such studies, the function may be more important than being able to batch cells.
When thawing PBMC, it is also important to know appropriate media and timing to minimize cell damage and death. 9 It is critical to warm quickly and briefly to minimize osmotic damage and toxic effects of dimethylsulfoxide (DMSO), and then to transfer the cells rapidly into appropriate media. In addition, timing of thawing matters for downstream applications. If the thawed PBMCs are to be used for a functional assay, a rest at high cell concentrations for several hours to overnight is often helpful. 10 There is a great deal of variation in the protocols for each step, often without data to support 1 approach versus another. The goal of this resource is to help researchers identify the most important factors for their experiments and provide them with the available data on selecting PBMC preparation and storage protocols so that they can standardize their assays and have confidence in their results. 
Collection of Human Blood

Method
Critical Parameter
It is important to select the right type of blood collection tubes based on the purpose of planned downstream applications. 
Methods
(1) Obtain 10-mL tubes of patient blood in the appropriate type of collection tubes (see Table 1 for guidance). If the blood cannot be processed immediately, store it at room temperature (RT) on a rocker and process within 24 hours; however, it is always best to process immediately (see Critical Parameters section). (2) Gently invert the tubes 8 times to mix the blood and use a 10-mL serological pipette to transfer 10 mL of blood to a 50-mL conical tube. Rinse each blood tube with 10-mL sterile saline solution and add to the 50-mL conical tube.
There should be approximately 20 mL of blood/phosphatebuffered saline in each tube. (3) Using a 10-mL serological pipette carefully underlay the diluted blood with 10 mL of Ficoll (at RT) being careful to avoid mixing the 2 layers. Do not dispense Ficoll from the pipette until the tip is at the bottom, and angle it slightly to avoid pressure on the base of the tube. Set the pipette speed to slow for the first 5 to 6 mL to avoid mixing layers. Stop dispensing Ficoll when there are about 500 μL left in the tip of the pipette to avoid blowing bubbles. Slowly withdraw the pipette from the tube, and the final 500 μL of Ficoll will release into the tube through gravity. Note: If it is important to also get rid of platelets, reduce centrifugation speed for this step to 129g. The lower centrifugation speed prevents pelleting of platelets, 12 but the PBMC pellet will also be loose. Therefore, it is important to remove the supernatant immediately after the spin, using a pipette. When removing media, leave approximately 1 mL behind. Decanting or waiting risks loss of cells. (10) Remove supernatant and resuspend in appropriate media for the application. (11) Count the cells using Trypan Blue and the hemocytometer or an automated cell counter (per manufacturer's instructions). The accuracy of this count is extremely important because we will use it to calculate leukocyte subpopulations so please be consistent. If RBC contamination is a concern (see Troubleshooting), repeat the count with another cell aliquot using one of the following methods (a) Addition of acetic acid lyses RBC.
(b) Stain with a mixture of acridine orange (AO) and ethidium bromide (EtBr) or propidium iodide (PI) 13 and count the cells using a microscope equipped with a ultraviolet lamp. Note: AO is a membrane-permeable dye that stains nucleated viable cells green, and EtBr and PI are membrane-impermeable and stain nonviable nucleated cells. AO and EtBr/PI do not stain RBCs because they are non-nucleated cells. (12) If freezing the cells, move on to the cryopreservation protocol below. If not, spin the 15-mL tubes 1 final time at 310 to 400g for 6 to 7 minutes with the brake ON and prepare for downstream applications.Alternative: There are several commercially available approaches to isolation of PBMCs that can be used instead of Ficoll. These could be used according to their manufacturer's instructions.
Cryopreservation of Human PBMC
Materials
(1) Laminar flow biosafety cabinet (2) −80°C freezer (3) Liquid nitrogen (−140°C) storage unit (4) Cell freezing devices such as Mr. Frosty (Nalgene or equivalent), CoolCell (Biocision), or electronic controlled rate freezer (Thermo or equivalent).
(5) Previously isolated/quantitated human PBMC (6) DMSO (eg, Sigma, cat D2650) (7) Heat-inactivated 14 fetal bovine serum (FBS) (8) Cryovials (2 mL size) (eg, Corning Inc. cat 430659) (9) Labels 
Methods
This protocol contains 2 alternative versions, both of which involve a final cryopreservation medium of FBS with 10% DMSO. The first method involves direct resuspension of cell pellets in FBS with 10% DMSO, with cryopreservation media at RT. The second involves resuspension of cell pellets in 50% of the required volume in 100% FBS, followed by addition of 2Â cryopreservation media (FBS with 20% DMSO) at 4°C. Where the protocols diverge, the second protocol is explained in italics. The rationale for both is explained under Considerations and Alternatives. Alternative protocol: use cryopreservation media at 4°C.
Label Cryovials
(a) To estimate number of vials, in general, a single cryovial should contain between 5 and 50 Â 10 6 isolated PBMC in 1 mL of freezing media, depending on the downstream application. (b) Label vials with at minimum: study name/number, investigator, subject number, date specimen was collected from the subject, and cell quantity. Alternative to thawing in water bath, an electronic thawing device such as Thawstar can be used. handling before freezing, such as extended time with cells in cryopreservation media at RT or using old freezing media. It may also be due to leaving cells at −80°C for too long before moving to LN 2 . Handling during freezing, storage, and thawing are further discussed in critical parameters (below). (E) High cell death after rest: This often results if the cell numbers were unexpectedly low before the rest-low cell numbers are indicative of poor survival during freezing and thawing, and those that remain are likely to be in poor condition. This can also result from inappropriate protocol for resting the cells (eg, 2 mL in a flask).
Considerations and Alternatives
Time considerations
A) For freezing: The freezing protocol can take as little as 30 minutes, once the media is ready. Controlled rate freezing (see critical parameters) can take up to 2 hours. Because of the importance of moving the cells to the freezer immediately after resuspension in media containing DMSO, it is crucial to allot sufficient time to complete the procedure without stopping. (B) For thawing: The main time considerations for thawing are to have everything ready before removing the cryovials from LN 2 , and to rapidly transfer cells from the cryovial to the tube containing media. (C) For functional assays: the rest of thawed cells is recommended to allow the cells to recover from the stress of cryopreservation. If the functional assay calls for an overnight or longer stimulation, it works well to start thawing the morning, rest the cells for several hours during the day, and start the stimulation at the end of the day. If shorter 4-to 6-hour stimulation is called for, it may be better to thaw cells later in the day, rest overnight so that the stimulation can start in the morning the next day.
Critical Parameters
There are many published protocols on preparation, freezing, and thawing of PBMC, which have many similarities but also differ in a variety of ways. These differences include composition of freezing media, temperature of freezing media, and time of exposure to DMSO. The critical parameters below comprise a list of the factors that we have found to be necessary to successful freezing and thawing of viable cells.
(A) Blood storage before processing: It is best to process the blood soon after collection. Longer storage is correlated with more granulocyte and/or RBC contamination and reduced response of T cells. When shipment and storage is a must, it is best to keep the cells at RT. Lower (4°C) temperatures cause higher contamination of granulocytes after Ficoll separation. There are reports that human Th17 T cells do not survive if whole blood is cooled to 4°C before PBMC isolation (Chong and Alegre, personal communication). Gentle agitation on a rocker helps to reduce granulocyte contamination.
compared with careful manual counting before relying on an automated counter. In addition, it is important to select a counter that allows discrimination between live and dead cells and use methods specific for the individual counter. (D) Quality of cryopreservation media: Regular preparation of fresh cryopreservation media is recommended due to the tendency of DMSO to oxidize to toxic substances. We recommend using DMSO in previously prepared single use aliquots or supplied in sealed single-use ampules instead of bottles for repeated use. Fetal bovine serum should also not be stored at 4°C for longer than 1 month, due to the potential for degradation or contamination. We observed that 10% DMSO in FBS provides improved viability and recovery when compared with cryomedium made of 10% DMSO in various concentrations of human AB serum (data not shown). When animal products are not permissible for downstream applications due to concerns of antigens present in FBS or need for good manufacturing practice compliance, commercial serum-free medium can be used, such as CS5 (5% DMSO) and CS10 (10% DMSO) from Biolife. (E) 1Â versus 2Â cryopreservation media: The use of 2Â cryopreservation media after resuspension in FBS allows for better control of the time the cells spend in DMSO, avoids direct resuspension in DMSO, and allows for cooling of the cells before addition of DMSO (see "Freezing rate" below). However, many researchers have successfully cryopreserved cells with direct resuspension in FBS with 10% DMSO. Exposure to 10% DMSO for up to an hour is not toxic, but it quickly becomes toxic after that, 17 which is why cells need to be transferred to a freezer quickly after addition of DMSO. We have observed similar viability of cells frozen with 1Â and 2Â cryopreservation media (data not shown). (F) Cell concentration: The recommended freezing concentration for human PBMC is 10 Â 10 6 to 50 Â 10 6 cells/mL. 18 We tested cryopreservation at density below 10 Â 10 6 /mL by freezing cells at a variety of concentrations between 2 Â 10 6 and 10 Â 10 6 cells/mL. There was no statistically significant difference in post-thaw recovery based on concentration ( Figure 2A) . Therefore, it is reasonable to choose from a range of concentrations based on downstream applications without risking reduced viability. Because the samples were a mix of healthy volunteer (HV) and transplant patients pretransplant and posttransplant, we also compared recovery between groups. There was no statistically significant difference in recovery based on patient status (Figure 2B ). (G) Freezing rate: There is substantial data that the rate of freezing effects both cell viability and functionality. The quoted "optimal" rate of freezing is approximately 1°C/ minute. 19 Published data indicate very little difference in survival with media at 4°C or RT, 20 indicating that cooling media before freezing is not necessary to prevent DMSO toxicity. Therefore, choosing a freezing media temperature on the basis of other experimental requirements is acceptable. As cells freeze, intracellular water is able to exit the cells due to osmotic pressure gradients. When cooled too quickly, water remaining inside the cells freezes, forming crystals that damage the cells. Conversely, cooling too slowly prolongs contact with toxic effects of DMSO. Electronic controlled rate freezers can precisely regulate the cooling rate during freezing. However, the equipment is expensive and requires a substantial volume of liquid nitrogen to operate. Mr. Frosty is a portable nonelectronic device that aims at controlled rate freezing. The outer container of Mr. Frosty is filled with isopropanol as a mechanism to control the temperature incline in the inner container where cryovials are housed. The isopropanol should be changed every five uses. The CoolCell cell-freezing devices can achieve 1°C/minute freezing rate in a −80°C freezer without additional electronics or solutions. We found that these devices, where properly used, performed comparably to an electronic controlled rate freezer ( Figure 3) . (H) Storage temperature below −80°C. Long-term storage in liquid nitrogen is essential to avoid significant loss of functional activity in human PBMC. There remains residual metabolic activity even at −80°C, because molecular movement does not fully stop until cells reach the glass transition of water, around −130°C. 21 Storage either in the liquid phase or vapor phase of a liquid nitrogen freezing system is sufficient to fully freeze any water present and eliminate metabolic activity. (I) Temperature increases after cells are frozen. Once transferred to liquid nitrogen, vials and cells must not be allowed to warm. Boxes should be kept in the vapor phase of liquid N 2 during any transfers. Cryovials should be handled from the lids rather than on the sides of tubes to avoid any potential warming. Should cells need to be transported long distances, this should be done in liquid nitrogen-even the temperature of dry ice (approximately −75°C) for shipping will warm the cells and thus decrease viable recovery. /mL dramatically enhanced the responsiveness of the cells in later assays. 10 The study found that high-density preculture allowed autologous monocytes to prime the T cells by capping T-cell receptors and increasing basal tyrosine phosphorylation. Although this study did not compare PBMC rest at high and low density after thaw, it is conceivable that resting culture density can affect the responsiveness of the T cells. Make sure to choose the appropriate TC container for the cell numbers. For example, 2 mL of cells in a 10-mL flask risks drying out, and cell death. Or putting cells in one well of a 6-well plate while the others are empty may risk evaporation; put media in other wells of a plate to minimize evaporation risk.
Summary
This standard operating procedure provides information on standardization of blood collection, PBMC isolation, cryopreservation and thawing. Many variables affect cell viability, recovery, and functionality. Alternatives provided in this standard operating procedure will allow for selection of an optimal protocol for the needs of each specific study. We recommend choosing 1 method for preparation of all samples to minimize experimental variability.
